Leading the Way in Life Science Technologies

GEN Exclusives

More »

Market and Technology Analysis

More »
Sep 19, 2013

Stem Cells in the EU: Northern and Central Markets

Learn about stem cell institutions and opportunities in the U.K., Germany, the Netherlands, Belgium, and Sweden in this incisive report.

Stem Cells in the EU: Northern and Central Markets

The markets of northern and central Europe are ones to watch. [© beugdesign - Fotolia.com]

  • The focus of this GEN Market & Tech Analysis Report is to present some characteristics of selected Northern/Central EU markets vis-à-vis institutions, funding/opportunities in the broader stem cells field [and focusing as appropriate on stem cell banking, iPSCs, cord blood]. We present here data collected by our U.K. research team via primary market research from across Europe focusing on the following countries:

    • U.K.
    • Germany
    • The Netherlands
    • Belgium
    • Sweden

    Taken together, these data frame some of the characteristics, institutions as well as stem cell research opportunities in these countries. In a future GENReport, we will provide an analysis of the regulatory landscape in selected EU countries.

    CLICK HERE to download the PDF report.



Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »